ACI for Ankle Cartilage DefectsMicrofracture produces fibrocartilage that deteriorates within two to three years for ankle cartilage lesions over 15 mm in diameter; autologous chondrocyte implantation regenerates more durable, hyaline-like cartilage that more closely resembles native tissue for larger defects.Microfracture produces fibrocartilage that deteriorates within two to three years for ankle cartilage lesions over 15 mm in diameter; autologous chondrocyte implantation regenerates more durable, hyaline-like cartilage that more closely resembles native tissue for larger defects.
Who qualifies for ChondroFiller Liquid Cartilage injectionChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.ChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.
ChondroFiller injection costs in the UK and EuropeChondroFiller costs £3,000–£8,000 in the UK, scaled by defect size, delivered as an ultrasound-guided outpatient injection with no surgery or anaesthetic.ChondroFiller costs £3,000–£8,000 in the UK, scaled by defect size, delivered as an ultrasound-guided outpatient injection with no surgery or anaesthetic.
When knee cartilage repair is worth consideringCartilage lacks a blood supply and cannot self-heal, but surgical or minimally invasive repair can restore focal defects in otherwise healthy joints, potentially delaying knee replacement by years or decades.Cartilage lacks a blood supply and cannot self-heal, but surgical or minimally invasive repair can restore focal defects in otherwise healthy joints, potentially delaying knee replacement by years or decades.
ChondroFiller for Shoulder Cartilage DefectsFocal shoulder cartilage defects are now treatable with a single ultrasound-guided collagen injection that recruits the body's own repair cells, forming hyaline-like tissue over 12 months without surgery or general anaesthetic.Focal shoulder cartilage defects are now treatable with a single ultrasound-guided collagen injection that recruits the body's own repair cells, forming hyaline-like tissue over 12 months without surgery or general anaesthetic.
The cost of leaving a knee cartilage defect untreatedKnee cartilage defects do not heal because cartilage lacks blood supply; defects widen under load with each step, spreading damage to surrounding tissue and progressing towards osteoarthritis if untreated.Knee cartilage defects do not heal because cartilage lacks blood supply; defects widen under load with each step, spreading damage to surrounding tissue and progressing towards osteoarthritis if untreated.
Recovery after a ChondroFiller injectionChondroFiller works by recruiting the body's progenitor cells into a collagen scaffold to regenerate cartilage; improvement takes six to twelve weeks, not days.ChondroFiller works by recruiting the body's progenitor cells into a collagen scaffold to regenerate cartilage; improvement takes six to twelve weeks, not days.
ChondroFiller injection safety: what the evidence showsOver 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).Over 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).
What ChondroFiller's CE approval means for UK patientsChondroFiller recruits the body's progenitor cells to repair focal cartilage defects, achieving symptom relief in 70–85% of selected patients, though it offers no benefit for widespread osteoarthritis.ChondroFiller recruits the body's progenitor cells to repair focal cartilage defects, achieving symptom relief in 70–85% of selected patients, though it offers no benefit for widespread osteoarthritis.
AMIC vs MACI for knee cartilage repairStandalone microfracture for knee cartilage defects has less than 60% survivorship at three years; AMIC adds a collagen membrane to stabilize repair, whilst MACI uses cultured chondrocytes and shows superiority in the SUMMIT trial for lesions over 3 cm².Standalone microfracture for knee cartilage defects has less than 60% survivorship at three years; AMIC adds a collagen membrane to stabilize repair, whilst MACI uses cultured chondrocytes and shows superiority in the SUMMIT trial for lesions over 3 cm².
What the ChondroFiller evidence actually showsChondroFiller's reoperation rate of 3–8% substantially outperforms microfracture (41%) and ACI/MACI (37%), reflecting its mechanism: the scaffold supports hyaline-like cartilage repair rather than the fibrocartilage scar tissue that other approaches produce.ChondroFiller's reoperation rate of 3–8% substantially outperforms microfracture (41%) and ACI/MACI (37%), reflecting its mechanism: the scaffold supports hyaline-like cartilage repair rather than the fibrocartilage scar tissue that other approaches produce.
How single-stage ACI differs from MACIMACI repairs cartilage defects over two operations, with weeks between them for external cell expansion; STACi compresses the entire process—harvesting, processing, and implantation—into a single surgical session.MACI repairs cartilage defects over two operations, with weeks between them for external cell expansion; STACi compresses the entire process—harvesting, processing, and implantation—into a single surgical session.